[Toxic shock syndrome in pyogenic arthritis]

Area of Science:

• Infectious Diseases
• Rheumatology
• Toxicology

Background:

• Toxic Shock Syndrome (TSS) is a severe, multi-system illness typically associated with Staphylococcus aureus exotoxins.
• Pyogenic arthritis is a joint infection caused by bacteria, leading to inflammation and potential joint destruction.
• Staphylococcus aureus is a common pathogen capable of producing various toxins, including those implicated in TSS.

Observation:

• This report details two cases of patients presenting with pyogenic arthritis caused by Staphylococcus aureus.
• Both patients were diagnosed with toxic shock syndrome, confirmed by the production of specific Staph. aureus toxins: enterotoxin F and pyogenic exotoxin C.
• One patient developed ischemic complications in both lower extremities, a potentially serious adverse event.

Findings:

• The study confirms a link between Staphylococcus aureus strains producing enterotoxin F and pyogenic exotoxin C and the development of toxic shock syndrome in patients with pyogenic arthritis.
• Ischemic complications, specifically in the lower extremities, were observed in one patient, raising questions about potential iatrogenic causes.
• The potential role of a heparin-dihydroergotamine combination, used for deep vein thrombosis prophylaxis, is highlighted as a possible contributing factor to the ischemic event.

Implications:

• These findings underscore the importance of recognizing toxic shock syndrome in patients with Staph. aureus pyogenic arthritis, even in non-menstrual settings.
• The specific toxins involved (enterotoxin F and pyogenic exotoxin C) may be crucial diagnostic and therapeutic targets.
• Clinicians should be vigilant about potential vascular complications and drug interactions, such as with heparin-dihydroergotamine, in patients with severe Staph. aureus infections.